Author:
Petrushkin Harry,Sethi Charanjit,Potter Jessica,Martin Laura,Russell Georgina,White Veronica,Ajamil-Rodanes Sofia,Brown Michael,Breen Ronan,Lipman Marc,Cropley Ian,McDermott Rory,Roche Anita,Booth Helen,Milburn James,Darmalingam Mathina,Lee Richard,Pavesio Carlos,Stanford Miles,Kon Onn Min,Bothamley Graham
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Lou SM, Montgomery PA, Larkin KL, Winthrop K, Zierhut M, Rosenbaum JT, et al. Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm. 2015;23:32–9.
2. Tomkins-Netzer O, Leong BCS, Zhang X, Lightman S, McCluskey PJ. Effect of antituberculous therapy on uveitis associated with latent tuberculosis. Am J Ophthalmol. 2018;190:164–70.
3. Gunasekeran DV, Agrawal R, Agarwal A, Carreno E, Raje D, Aggarwal K, et al. THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina. 2018;39:1623–30.
4. Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm. 2017;3:1–9.
5. The European Medicine’s Agency final recommendation on quinolone and fluoroquinolone containing medicinal products. 2019. p. 2–4.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献